Modified immune cells target rare muscle disease in new trial
NCT ID NCT07391605
Summary
This study is testing whether a new cell therapy called Descartes-08 can help control symptoms of dermatomyositis and antisynthetase syndrome, rare autoimmune diseases that cause muscle weakness and skin rashes. The trial will enroll 60 adults whose symptoms haven't improved enough with standard medications. Participants will be randomly assigned to receive either the experimental cell therapy or a placebo to compare safety and effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTISYNTHETASE SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.